PEDIATRICS Vol. 65 No. 6 June 1980, pp. 1166-1169
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Wendt, L.
Right arrow Articles by Koivisto, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Wendt, L.
Right arrow Articles by Koivisto, M.

Failure of Strychnine Treatment during the Neonatal Period in Three Finnish Children with Nonketotic Hyperglycinemia

Lennart von Wendt MD1, Seppo Similä MD1, Anna-Liisa Saukkonen MD1, and Maila Koivisto MD1

1 Department of Paediatrics, University of Oulu, Oulu, Finland

Three Finnish infants with a severe neonatal-onset-type of nonketotic hyperglycinemia were treated with strychnine nitrate in a daily dosage of 0.2 to 0.9 mg/kg, given orally in four doses. In order to lower the plasma and CSF-glycine concentrations concomitant exchange transfusions (200 to 300 ml/kg of heparinized blood) were carried out in two of these infants. Although the strychnine therapy was started at ages 15, 40, and 62 hours, the strychnine produced no clinical effect, and the exchange transfusion caused only a transient decrease in the plasma glycine level. Despite treatment, the clinical course was the same as in the majority of children with the severe form of the disease—all died within the first ten days of life. Impressive effects of strychnine treatment initiated in two infants at ages 5 and 6frac12 months, and given in addition to sodium benzoate and anticonvulsants, have been reported. These cases, however, probably represent a less severe type of nonketotic hyperglycinemia. Nevertheless, the therapeutic failure in the present cases probably indicates that strychnine treatment does not solve the therapeutic problems of severe forms of NKH.




This article has been cited by other articles:


Home page
 J Child NeurolHome page
M. R. Pranzatelli
Topical Review: Antidyskinetic Drug Therapy for Pediatric Movement Disorders
J Child Neurol, September 1, 1996; 11(5): 355 - 369.
[Abstract] [PDF]

Home page
 CLIN PEDIATRHome page
K. Sankaran, R.E. Casey, W.A. Zaleski, and I.M. Mendelson
Glycine Encephalopathy in a Neonate: Treatment with Intravenous Strychnine and Sodium Benzoate
Clinical Pediatrics, October 1, 1982; 21(10): 636 - 637.
[PDF]